ANN ARBOR — Ann Arbor-based Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had received shareholder approval to change its corporate name to Synthetic Biologics Inc.

Synthetic Biologics is a pharmaceutical company developing therapeutics and medicines based on synthetic DNA. Company officials said the new name more accurately reflects the company’s business.

Company officials said it’s expected that the company’s shares will start trading under its new name and stock ticker symbol, “SYN,” on Thursday.

Synthetic Biologics’ common stock has been assigned a new CUSIP number of 87163U102 in connection with the name change. Outstanding stock certificates are not affected by the name change and will not need to be exchanged.

Synthetic Biologics is developing, or has partnered the development of, product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis.

More at

  1. hempangle says:

    As soon as the people of the United States get tired of people getting killed by these drug companys with their drugs than we can start saving lives for everyone.Wright now only the few are helping themselves survive bad illness’s.When the brainwashing started i don’t know.I see people sitting in the parking lots of hospitals smoking pot until they have to go in and get their chemotherapy drug treatments.Never once has the government told these people that all they have to do is ingest the oils that come from the pot their smoking and it will cure their cancer,not once.Satins work is all around us.In God We Trust is on our bills and until this is really the truth than most of you will never see a cure like i know aboutThe cure is illegal to have,but it is a cure and not just a treatment.

Leave a Reply